Sinden JD - Search Results

1

Immortalized human fetal retinal cells retain progenitor characteristics and represent a potential source for the treatment of retinal degenerative disease.

Hasan SM, Vugler AA, Miljan EA, Sinden JD, Moss SE, Greenwood J. Hasan SM, et al. Among authors: sinden jd. Cell Transplant. 2010;19(10):1291-306. doi: 10.3727/096368910X505477. Epub 2010 May 4. Cell Transplant. 2010. PMID: 20447347 Free article.

2

Efficacy and Safety of Human Retinal Progenitor Cells.

Semo M, Haamedi N, Stevanato L, Carter D, Brooke G, Young M, Coffey P, Sinden J, Patel S, Vugler A. Semo M, et al. Transl Vis Sci Technol. 2016 Jul 19;5(4):6. doi: 10.1167/tvst.5.4.6. eCollection 2016 Jul. Transl Vis Sci Technol. 2016. PMID: 27486556 Free PMC article.

3

Growth kinetics and transplantation of human retinal progenitor cells.

Aftab U, Jiang C, Tucker B, Kim JY, Klassen H, Miljan E, Sinden J, Young M. Aftab U, et al. Exp Eye Res. 2009 Sep;89(3):301-10. doi: 10.1016/j.exer.2009.03.025. Epub 2009 Jun 12. Exp Eye Res. 2009. PMID: 19524569

4

Molecular characterization of human retinal progenitor cells.

Schmitt S, Aftab U, Jiang C, Redenti S, Klassen H, Miljan E, Sinden J, Young M. Schmitt S, et al. Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5901-8. doi: 10.1167/iovs.08-3067. Epub 2009 Jun 24. Invest Ophthalmol Vis Sci. 2009. PMID: 19553622

5

Stem cell treatment of ischemic brain injury.

Miljan EA, Sinden JD. Miljan EA, et al. Among authors: sinden jd. Curr Opin Mol Ther. 2009 Aug;11(4):394-403. Curr Opin Mol Ther. 2009. PMID: 19649984 Review.

6

Differential development of neuronal physiological responsiveness in two human neural stem cell lines.

Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S, Edwards FA, Sinden JD. Donato R, et al. Among authors: sinden jd. BMC Neurosci. 2007 May 25;8:36. doi: 10.1186/1471-2202-8-36. BMC Neurosci. 2007. PMID: 17531091 Free PMC article.

7

c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain.

Stevanato L, Corteling RL, Stroemer P, Hope A, Heward J, Miljan EA, Sinden JD. Stevanato L, et al. Among authors: sinden jd. BMC Neurosci. 2009 Jul 21;10:86. doi: 10.1186/1471-2202-10-86. BMC Neurosci. 2009. PMID: 19622162 Free PMC article.

8

Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line.

Thomas RJ, Hope AD, Hourd P, Baradez M, Miljan EA, Sinden JD, Williams DJ. Thomas RJ, et al. Among authors: sinden jd. Biotechnol Lett. 2009 Aug;31(8):1167-72. doi: 10.1007/s10529-009-9989-1. Epub 2009 Apr 3. Biotechnol Lett. 2009. PMID: 19343502

9

A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke.

Pollock K, Stroemer P, Patel S, Stevanato L, Hope A, Miljan E, Dong Z, Hodges H, Price J, Sinden JD. Pollock K, et al. Among authors: sinden jd. Exp Neurol. 2006 May;199(1):143-55. doi: 10.1016/j.expneurol.2005.12.011. Epub 2006 Feb 7. Exp Neurol. 2006. PMID: 16464451

10

Implantation of c-mycER TAM immortalized human mesencephalic-derived clonal cell lines ameliorates behavior dysfunction in a rat model of Parkinson's disease.

Miljan EA, Hines SJ, Pande P, Corteling RL, Hicks C, Zbarsky V, Umachandran M, Sowinski P, Richardson S, Tang E, Wieruszew M, Patel S, Stroemer P, Sinden JD. Miljan EA, et al. Among authors: sinden jd. Stem Cells Dev. 2009 Mar;18(2):307-19. doi: 10.1089/scd.2008.0078. Stem Cells Dev. 2009. PMID: 18554088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters